Fletcher CV - Search Results

1

Strategies for control of zidovudine concentrations in serum.

Noormohamed SE, Henry WK, Rhame FS, Balfour HH Jr, Fletcher CV. Noormohamed SE, et al. Among authors: fletcher cv. Antimicrob Agents Chemother. 1995 Dec;39(12):2792-7. doi: 10.1128/AAC.39.12.2792. Antimicrob Agents Chemother. 1995. PMID: 8593022 Free PMC article. Clinical Trial.

2

Comparative pharmacokinetics of zidovudine in healthy volunteers and in patients with AIDS with and without hepatic disease.

Fletcher CV, Rhame FS, Beatty CC, Simpson M, Balfour HH Jr. Fletcher CV, et al. Pharmacotherapy. 1992;12(6):429-34. Pharmacotherapy. 1992. PMID: 1492005

3

Cytomegalovirus infections in the immunocompromised transplant patient. Prevention of cytomegalovirus disease with oral acyclovir.

Balfour HH Jr, Fletcher CV, Dunn D. Balfour HH Jr, et al. Among authors: fletcher cv. Transplant Proc. 1991 Apr;23(2 Suppl 1):17-9. Transplant Proc. 1991. PMID: 1647558 Clinical Trial. No abstract available.

4

Pharmacologic basis for high-dose oral acyclovir prophylaxis of cytomegalovirus disease in renal allograft recipients.

Fletcher CV, Englund JA, Edelman CK, Gross CR, Dunn DL, Balfour HH Jr. Fletcher CV, et al. Antimicrob Agents Chemother. 1991 May;35(5):938-43. doi: 10.1128/AAC.35.5.938. Antimicrob Agents Chemother. 1991. PMID: 1649575 Free PMC article. Clinical Trial.

5

Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir.

Dunn DL, Mayoral JL, Gillingham KJ, Loeffler CM, Brayman KL, Kramer MA, Erice A, Balfour HH Jr, Fletcher CV, Bolman RM 3rd, et al. Dunn DL, et al. Among authors: fletcher cv. Transplantation. 1991 Jan;51(1):98-106. doi: 10.1097/00007890-199101000-00015. Transplantation. 1991. PMID: 1846255 Clinical Trial.

6

Acyclovir therapy in neonates.

Englund JA, Fletcher CV, Balfour HH Jr. Englund JA, et al. Among authors: fletcher cv. J Pediatr. 1991 Jul;119(1 Pt 1):129-35. doi: 10.1016/s0022-3476(05)81053-4. J Pediatr. 1991. PMID: 2066845

7

Evaluation of ganciclovir for cytomegalovirus disease.

Fletcher CV, Balfour HH Jr. Fletcher CV, et al. DICP. 1989 Jan;23(1):5-12. doi: 10.1177/106002808902300101. DICP. 1989. PMID: 2541566 Review.

8

Continuous infusion of high-dose acyclovir for serious herpesvirus infections.

Fletcher CV, Englund JA, Bean B, Chinnock B, Brundage DM, Balfour HH Jr. Fletcher CV, et al. Antimicrob Agents Chemother. 1989 Aug;33(8):1375-8. doi: 10.1128/AAC.33.8.1375. Antimicrob Agents Chemother. 1989. PMID: 2552909 Free PMC article.

9

Pharmacokinetics and safety of high-dose oral acyclovir for suppression of cytomegalovirus disease after renal transplantation.

Fletcher CV, Chinnock BJ, Chace B, Balfour HH Jr. Fletcher CV, et al. Clin Pharmacol Ther. 1988 Aug;44(2):158-63. doi: 10.1038/clpt.1988.131. Clin Pharmacol Ther. 1988. PMID: 2840229

10

Ganciclovir pharmacokinetics during renal impairment.

Lake KD, Fletcher CV, Love KR, Brown DC, Joyce LD, Pritzker MR. Lake KD, et al. Among authors: fletcher cv. Antimicrob Agents Chemother. 1988 Dec;32(12):1899-900. doi: 10.1128/AAC.32.12.1899. Antimicrob Agents Chemother. 1988. PMID: 2854457 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

231 results

Search Page

Filters